Alaunus Biosciences
South San Francisco, CA · Medtech
A multi-analyte diagnostic assay measuring protease activity and mass-based biomarkers in thyroid fine needle aspirates to differentiate malignant from benign nodules.
alaunusbio.com →- Grants
- $4.1M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of fluorogenic substrates for the diagnosis of pancreatic cysts | $235,341 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of fluorogenic substrates for the diagnosis of pancreatic cysts | $235,341 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of activity-based biomarkers for risk stratification of indeterminate thyroid nodules | $264,718 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of activity-based biomarkers for risk stratification of indeterminate thyroid nodules | $264,718 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules | $1,567,219 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules | $871,193 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules | $696,026 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1356 | VIVARAY INC | — | $600K |
| 1357 | Sonendo, Inc. | — | $238M |
| 1358 | LAP IQ, INC. | — | — |
| 1359 | Alaunus Biosciences | — | — |
| 1360 | CONSENSUS NETWORKS INC. | — | — |
| 1361 | BIODATA CONSORTIUM, LLC | — | — |
| 1362 | ROKHAN, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Peptidase Cleavable Substrates And Methods Of Identification And Use Thereofapplication
- Peptidase Cleavable Substrates And Methods Of Identification And Use Thereofapplication
- Peptidase Cleavable Substrates And Methods Of Identification And Use Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.